CHU (Hôpital Calmette) - Pneumologie
About CHU (Hôpital Calmette) - Pneumologie
"Hôpital public à Lille"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Intergroupe Francophone de Cancerologie Thoracique
6
Hoffmann-La Roche
5
Clinical Trials at CHU (Hôpital Calmette) - Pneumologie
During the past decade, CHU (Hôpital Calmette) - Pneumologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on
average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)
2010-03-01
2015-12-01
Completed
106
A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
2011-06-25
2016-06-25
Completed
485
Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR
2012-05-15
2020-06-17
Completed
379
Strategies for Maintenance Therapies in Advanced Non Small Cell Lung Cancer
2012-07-01
2017-11-30
Completed
932
French National Observatory of the Patients With Non-small Cell Lung (NSCLC) and Molecular Testings
2012-04-01
2013-04-01
Completed
18,858
A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
2013-07-31
2017-01-02
Completed
1,081
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "CHU (Hôpital Calmette) - Pneumologie"
#1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 2 trials as a collaborator and "University Hospital, Caen" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at CHU (Hôpital Calmette) - Pneumologie
According to Clinical.Site data, the most researched conditions in "CHU (Hôpital Calmette) - Pneumologie" are
"Idiopathic Pulmonary Fibrosis" (3 trials), "ALK Gene Mutation" (1 trials), "Advanced Non Small Cell Lung Cancer" (1 trials), "Asthma" (1 trials) and "BRAF Gene Mutation" (1 trials). Many other conditions were trialed in "CHU (Hôpital Calmette) - Pneumologie" in a lesser frequency.
Clinical Trials Intervention Types at CHU (Hôpital Calmette) - Pneumologie
Most popular intervention types in "CHU (Hôpital Calmette) - Pneumologie" are "Drug" (9 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (2 trials), "Docetaxel" (2 trials), "Erlotinib" (2 trials), "Lebrikizumab" (2 trials) and "Pemetrexed" (2 trials). Other intervention names were less common.
Clinical Trials Genders at CHU (Hôpital Calmette) - Pneumologie
The vast majority of trials in "CHU (Hôpital Calmette) - Pneumologie" are
10 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at CHU (Hôpital Calmette) - Pneumologie
Currently, there are NaN active trials in "CHU (Hôpital Calmette) - Pneumologie".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in CHU (Hôpital Calmette) - Pneumologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CHU (Hôpital Calmette) - Pneumologie, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".